{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:47:12Z","timestamp":1791362832281,"version":"4.3.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ejps.2015.06.017","type":"journal-article","created":{"date-parts":[[2015,6,20]],"date-time":"2015-06-20T09:18:04Z","timestamp":1434791884000},"page":"189-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Monitoring of mycophenolate mofetil metabolites in children with nephrotic syndrome and the proposed novel target values of pharmacokinetic parameters"],"prefix":"10.1016","volume":"77","author":[{"given":"Joanna","family":"Sobiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matylda","family":"Resztak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta","family":"Ostalska-Nowicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Zachwieja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"G\u0105siorowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiktoria","family":"Piechanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Chrzanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2015.06.017_b0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s40262-013-0124-z","article-title":"How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?","volume":"53","author":"Abd Rahman","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.06.017_b0010","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.12678","article-title":"Exposure-effect relationship of mycophenolic acid and prednisolone in adult lupus nephritis patients","author":"Abd Rahman","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.06.017_b0015","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00467-007-0617-9","article-title":"Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome","volume":"22","author":"Afzal","year":"2007","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejps.2015.06.017_b0020","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/FTD.0000000000000031","article-title":"Pharmacokinetics of concentration-controlled mycophenolate mofetil in proliferative lupus nephritis: an observational cohort study","volume":"36","author":"Alexander","year":"2014","journal-title":"Therap. Drug Monit."},{"key":"10.1016\/j.ejps.2015.06.017_b0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/jlts.2003.50022","article-title":"Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients","volume":"9","author":"Aw","year":"2003","journal-title":"Liver Transpl."},{"key":"10.1016\/j.ejps.2015.06.017_b0030","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/lt.21530","article-title":"Long-term outcome of mycophenolate mofetil rescue therapy for resistant acute allograft rejection in pediatric liver transplant recipients","volume":"14","author":"Aw","year":"2008","journal-title":"Liver Transpl."},{"key":"10.1016\/j.ejps.2015.06.017_b0035","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/lt.22364","article-title":"Optimization of the dosing regimen of mycophenolate mofetil in pediatric liver transplant recipients","volume":"17","author":"Barau","year":"2011","journal-title":"Liver Transpl."},{"key":"10.1016\/j.ejps.2015.06.017_b0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00467-011-2006-7","article-title":"Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trial","volume":"27","author":"Baudouin","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejps.2015.06.017_b0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bbmt.2009.10.007","article-title":"An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients","volume":"16","author":"Bhatia","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ejps.2015.06.017_b0050","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00007691-200210000-00004","article-title":"Mycophenolic acid and mycophenolic acid glucuronide pharmacokinetics in pediatric liver transplant recipients: effect of cyclosporine and tacrolimus comedication","volume":"24","author":"Brown","year":"2002","journal-title":"Therap. Drug Monit."},{"key":"10.1016\/j.ejps.2015.06.017_b0055","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/FTD.0b013e3181f01397","article-title":"Establishment of high-performance liquid chromatography and enzyme multiplied immunoassay technology methods for determination of free mycophenolic acid and its application in Chinese liver transplant recipients","volume":"32","author":"Chen","year":"2010","journal-title":"Therap. Drug Monit."},{"key":"10.1016\/j.ejps.2015.06.017_b0060","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00467-002-1057-1","article-title":"Mycophenolic acid pharmacokinetics in stable pediatric renal transplantation","volume":"18","author":"David-Neto","year":"2003","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejps.2015.06.017_b0065","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00467-009-1356-x","article-title":"Mycophenolate mofetil in children with steroid\/cyclophosphamide-resistant nephrotic syndrome","volume":"25","author":"de Mello","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejps.2015.06.017_b0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2125.2012.04305.x","article-title":"Paediatric use of mycophenolate mofetil","volume":"75","author":"Downing","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.06.017_b0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejps.2014.02.015","article-title":"Circadian variation of mycophenolate mofetil pharmacokinetics in rats","volume":"58","author":"Dridi","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2015.06.017_b0080","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jchromb.2007.09.036","article-title":"Liquid chromatographic determination of mycophenolic acid and its metabolites in human kidney transplant plasma: pharmacokinetic application","volume":"859","author":"Elbarbry","year":"2007","journal-title":"J. Chromatogr. Part B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ejps.2015.06.017_b0085","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1016\/S0041-1345(02)03508-X","article-title":"High mycophenolic acid area under-the-curve values in renal transplant recipients on long-term mycophenolate mofetil treatment","volume":"34","author":"Engelbertink","year":"2002","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejps.2015.06.017_b0090","first-page":"120","article-title":"Abbreviated mycophenolic acid AUC from C0, C1, C2, and C4 is preferable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy","volume":"17","author":"Filler","year":"2004","journal-title":"Transpl. Int."},{"key":"10.1016\/j.ejps.2015.06.017_b0095","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1399-3046.2006.00553.x","article-title":"Value of therapeutic drug monitoring of MMF therapy in pediatric transplantation","volume":"10","author":"Filler","year":"2006","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ejps.2015.06.017_b0100","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.transproceed.2007.03.049","article-title":"Optimization of immunosuppressive drug monitoring in children","volume":"39","author":"Filler","year":"2007","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejps.2015.06.017_b0105","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00467-003-1133-1","article-title":"Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children","volume":"18","author":"Filler","year":"2003","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejps.2015.06.017_b0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/FTD.0b013e31816ba73a","article-title":"Pharmacokinetics of mycophenolate mofetil and sirolimus in children","volume":"30","author":"Filler","year":"2008","journal-title":"Therap. Drug Monit."},{"key":"10.1016\/j.ejps.2015.06.017_b0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00467-006-0294-0","article-title":"A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome","volume":"22","author":"Fujinaga","year":"2007","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejps.2015.06.017_b0120","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00431-012-1913-3","article-title":"Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab","volume":"172","author":"Fujinaga","year":"2013","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ejps.2015.06.017_b0125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0091270010368542","article-title":"Inosine monophosphate dehydrogenase (IMPDH) activity as a pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipients","volume":"51","author":"Fukuda","year":"2011","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.06.017_b0130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5301\/JN.2011.6327","article-title":"Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome","volume":"24","author":"Gargah","year":"2011","journal-title":"J. Nephrol."},{"key":"10.1016\/j.ejps.2015.06.017_b0135","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1681\/ASN.2012121200","article-title":"Mycophenolate mofetil versus cyclosporine a in children with frequently relapsing nephrotic syndrome","volume":"24","author":"Gellermann","year":"2013","journal-title":"J. Am. Soc. Neprol."},{"key":"10.1016\/j.ejps.2015.06.017_b0140","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1399-0012.2008.00932.x","article-title":"Longitudinal evaluation of mycophenolic acid pharmacokinetics in pediatric kidney transplant recipients. The role of post-transplant clinical and therapeutic variables","volume":"23","author":"Ghio","year":"2009","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.ejps.2015.06.017_b0145","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1399-3046.2005.00335.x","article-title":"Mycophenolate mofetil suspension in pediatric renal transplantation: three-year data from the tricontinental trial","volume":"9","author":"H\u00f6cker","year":"2005","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ejps.2015.06.017_b0150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11936-010-0085-6","article-title":"Immunosuppression therapy for pediatric heart transplantation","volume":"12","author":"Irving","year":"2010","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"10.1016\/j.ejps.2015.06.017_b0155","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/0091270007313326","article-title":"Higher mycophenolate dose requirements in children undergoing hematopoietic cell transplant (HCT)","volume":"48","author":"Jacobson","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.06.017_b0160","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/01.tp.0000258587.70166.87","article-title":"Five-year outcome in pediatric patients with mycophenolate mofetil-based renal transplantation","volume":"83","author":"Jungraithmayr","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.ejps.2015.06.017_b0165","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1136\/adc.2009.178608","article-title":"Mycophenolate mofetil treatment in children and adolescents with lupus","volume":"95","author":"Kazyra","year":"2010","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ejps.2015.06.017_b0170","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00007691-200310000-00011","article-title":"Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil","volume":"25","author":"Kuypers","year":"2003","journal-title":"Therap. Drug Monit."},{"key":"10.1016\/j.ejps.2015.06.017_b0175","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00467-009-1375-7","article-title":"Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome","volume":"25","author":"Li","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejps.2015.06.017_b0180","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/lt.21274","article-title":"Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine","volume":"13","author":"Lobritto","year":"2007","journal-title":"Liver Transpl."},{"key":"10.1016\/j.ejps.2015.06.017_b0185","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00467-005-1877-x","article-title":"Mycophenolate mofetil in steroid\/cyclosporine-dependent\/resistant nephrotic syndrome","volume":"20","author":"Mendiz\u00e1bal","year":"2005","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejps.2015.06.017_b0190","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2710.2011.01269.x","article-title":"Effective plasma concentrations of mycophenolic acid and its glucuronide in systemic lupus erythematosus patients in the remission-maintenance phase","volume":"37","author":"Mino","year":"2012","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ejps.2015.06.017_b0195","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1093\/ndt\/gfn360","article-title":"Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil","volume":"23","author":"Neumann","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejps.2015.06.017_b0200","first-page":"346","article-title":"Mycophenolate mofetil for treatment of idiopathic nephrotic syndrome in children","volume":"6","author":"Nickavar","year":"2012","journal-title":"Iran. J. Kidney Dis."},{"key":"10.1016\/j.ejps.2015.06.017_b0205","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.5114\/aoms.2011.26618","article-title":"Mycophenolate mofetil (MMF) treatment efficacy in children with primary and secondary glomerulonephritis","volume":"7","author":"Ostalska-Nowicka","year":"2011","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.ejps.2015.06.017_b0210","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/FTD.0b013e3181c01d07","article-title":"Age-related variability of mycophenolate mofetil exposure in stable pediatric liver transplant recipients and influences of donor characteristics","volume":"31","author":"Parant","year":"2009","journal-title":"Therap. Drug Monit."},{"key":"10.1016\/j.ejps.2015.06.017_b0215","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/0961203308098631","article-title":"Mycophenolate mofetil in patients with systemic lupus erythematosus: a prospective pharmacokinetic study","volume":"18","author":"Roland","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.ejps.2015.06.017_b0220","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00228-011-1203-4","article-title":"Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acid","volume":"68","author":"Rother","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.06.017_b0225","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.phrs.2011.01.009","article-title":"Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome","volume":"63","author":"Saint-Marcoux","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejps.2015.06.017_b0230","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejps.2015.06.017_b0235","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007691-200408000-00002","article-title":"Using established immunosuppressant therapy effectively: lessons from the measurement of mycophenolic acid plasma concentrations","volume":"26","author":"Shaw","year":"2004","journal-title":"Therap. Drug Monit."},{"key":"10.1016\/j.ejps.2015.06.017_b0240","article-title":"Pharmacokinetics of mycophenolate sodium co-administered with tacrolimus in the first year after renal transplantation","author":"Sobiak","year":"2015","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.06.017_b0245","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients","volume":"46","author":"Staatz","year":"2007","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.06.017_b0250","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00204-014-1247-1","article-title":"Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update","volume":"88","author":"Staatz","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejps.2015.06.017_b0255","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.transproceed.2004.12.186","article-title":"Mycophenolic acid metabolite profile in renal transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil","volume":"37","author":"Tedesco-Silva","year":"2005","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejps.2015.06.017_b0260","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00467-004-1765-9","article-title":"Steroid withdrawal in pediatric and adult renal transplant recipients","volume":"20","author":"T\u00f6nshoff","year":"2005","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejps.2015.06.017_b0265","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.trre.2011.01.001","article-title":"Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation","volume":"25","author":"T\u00f6nshoff","year":"2011","journal-title":"Transplant. Rev. (Orlando)"},{"key":"10.1016\/j.ejps.2015.06.017_b0270","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.tp.0000186380.61251.fc","article-title":"The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantation","volume":"80","author":"van Gelder","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.ejps.2015.06.017_b0275","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1681\/ASN.V981511","article-title":"Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients","volume":"9","author":"Weber","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejps.2015.06.017_b0280","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1681\/ASN.V133759","article-title":"The pharmacokinetic\u2013pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: a report of the German Study Group on mycophenolate mofetil therapy","volume":"13","author":"Weber","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejps.2015.06.017_b0285","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/clinchem\/48.3.517","article-title":"Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal transplant recipients on mycophenolate mofetil therapy","volume":"48","author":"Weber","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejps.2015.06.017_b0290","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/FTD.0b013e31818752d9","article-title":"Long-term pharmacokinetics of mycophenolic acid in pediatric renal transplant recipients over 3years posttransplant","volume":"30","author":"Weber","year":"2008","journal-title":"Therap. Drug Monit."},{"key":"10.1016\/j.ejps.2015.06.017_b0295","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bcp.12392","article-title":"Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring","volume":"78","author":"Woillard","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.06.017_b0300","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2125.2010.03615.x","article-title":"Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome","volume":"69","author":"Zhao","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.06.017_b0305","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.transproceed.2006.06.042","article-title":"Mycophenolate mofetil (Cellcept) in pediatric renal transplantation","volume":"38","author":"Zimmerhackl","year":"2006","journal-title":"Transplant. Proc."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098715003127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098715003127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T13:03:52Z","timestamp":1652533432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098715003127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":61,"alternative-id":["S0928098715003127"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2015.06.017","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitoring of mycophenolate mofetil metabolites in children with nephrotic syndrome and the proposed novel target values of pharmacokinetic parameters","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2015.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}